Labor shortening drug tested in new study
NCT ID NCT07184099
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether the drug phloroglucinol can shorten the active phase of labor in pregnant women. Researchers gave the drug intravenously to 134 women aged 18-35 with full-term pregnancies. The goal was to see if it reduced the time from labor diagnosis to full cervical dilation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- phloroglucinol
- What this could lead to
- If it works, this could offer a simple way to shorten labor for some women, reducing discomfort and complications.
- What could go wrong
- This is a small, completed study with 134 participants. Results may not apply to all women, and the drug may not be effective or could cause side effects like allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LABOR are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Combined Military Hospital
Attock, Punjab Province, 43100, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Simple drug may prevent worrisome fetal heart tracings after epidural
- Warm water relief: showering during labor eases pain and anxiety
- Which drug speeds up labor for obese moms? new study aims to find out.
- Which labor starter works faster? catheter vs. pill showdown
- Chocolate power: could a sweet treat speed up labor?
- Could the way you push during labor reduce pain and fatigue?